A mother’s story: Finding care for her daughter
December 1, 2024"I wish someone had told me about HIV testing from the very beginning, so that my Savita* wouldn’t have ended up in your hospital in such a critical condition. No other child should have to go through the pain she...
Read more
South Sudan: How malnutrition is dangerously feeding the TB/HIV pandemic
May 30, 2024In South Sudan, over seven million people are expected to face acute food insecurity or worse between now and July. Among them, patients who are infected with tuberculosis and HIV are highly impacted since the intensity of the treatment is...
Read more
Malawi: “In 2001, when the counsellor said ART could prolong my life, I thought it would be two to three years but here I am, 22 years later”
August 7, 2023In July 2023, Médecins Sans Frontières (MSF) closed the chapter on one of its longest standing projects in Malawi, launched some 25 years ago in response to the HIV/AIDS epidemic. The MSF Saturday Teen Club in Chiradzulu on 7 March 2020...
Read more
From Nhlangano to the Future, MSF’s legacy in Shiselweni region: 5 key facts about MSF in Eswatini
May 31, 2023As Médecins Sans Frontières/Doctors Without Borders (MSF) prepares to leave the Shiselweni region after 16 years of work, its project in Nhlangano draws to a close. However, to ensure the continued success of the Shiselweni HIV & tuberculosis (TB) programme,...
Read more
Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production
May 11, 2023MSF calls on US based corporations Abbott and BD to ensure adequate supply of CD4 tests and equipment. Geneva, 11 May 2023 – In a new report released today, Médecins Sans Frontières/Doctors Without Borders (MSF) warned that access to point-of-care...
Read more
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
March 31, 2023With affordable generics likely years away, ViiV must make information public on supply of long-acting cabotegravir and global distribution plan to ensure access for people in high HIV burden low- and middle-income countries Geneva, 30 March 2023 – Today Médecins...
Read more
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
November 30, 2022MSF calls on ViiV to urgently dismantle barriers to access for long-acting cabotegravir Geneva, 29 November 2022 - Doctors Without Borders/Médecins Sans Frontières (MSF) today called on pharmaceutical corporation ViiV to urgently dismantle the barriers hindering broad access to the...
Read more
HIV/AIDS in the DRC: Behind the progress, huge challenges remain
November 25, 2022In 2002, Médecins Sans Frontières (MSF) teams opened the first outpatient treatment centre offering free care to people living with HIV in Kinshasa, the capital of the Democratic Republic of Congo (DRC). Twenty years later, while great progress has been achieved in the...
Read more
The healing touch
October 11, 2022MSF has been working in Bihar since 2007. Our activities have seen a gradual transition to focus on people living with advanced HIV and life-threatening opportunistic infections at Guru Gobind Singh Hospital in Patna, Bihar. For the unversed, patients with...
Read more
World AIDS Day: Why are people living with HIV still dying of AIDS in India?
December 1, 2021It is unacceptable that people living with HIV are still dying because the tests, treatment and care for life-threatening infections are not available Today on World AIDS Day, we mark four decades when mysterious illnesses started to take lives that...
Read more
Cryptococcal meningitis: This World AIDS Day, it’s time to recognise an outsider
December 1, 2021By Amir Shroufi, MSF South Africa Outsiders seldom get the attention they deserve. When it comes to conservation, for example, a few popular species attract most of the available funding – the rhino overshadows riverine rabbit. In the arts, jazz and...
Read more
Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug
July 21, 2021Today, as preliminary AMBITION trial results demonstrated a breakthrough in treatment of HIV-related cryptococcal meningitis, simplifying and shortening treatment by using a single dose of liposomal amphotericin B (L-AmB) in combination with existing oral therapy, Médecins Sans Frontières/Doctors Without Borders...
Read more
